Use of small peptides in the treatment of psoriasis
Use of somatostatin agonists and antagonists for treating diseas
Use of stem cell factor and soluble interleukin-6 receptor to in
Use of substances having oxytocin activity for preparation...
Use of substances with oxytocin activity against climacteric...
Use of substituted acryloyl distamycin derivatives in the...
Use of sugar derivatives for the prophylaxis and treatment of vi
Use of sugar derivatives for the prophylaxis and treatment of vi
Use of sulglicotide for the treatment of mucositis
Use of synthetic peptides to disrupt the cytoskeleton
Use of tasteless, hydrolyzed collagen and agent containing the s
Use of TGF-.beta..sub.3 to reduce the formation of scar tissue i
Use of TGF-.beta.3, to prevent or retard fistula closure followi
Use of the cathelicidin LL-37 and derivatives thereof for...
Use of the cytokine IP-10 as an anti-tumor agent
Use of the KAL protein and treatment with the KAL protein in tre
Use of the KAL protein and treatment with the KAL protein in...
Use of the long pentraxin PTX3 for the treatment of diseases...
Use of the polypeptide compound
Use of therapeutic human albumin for treatment of...